The Financial Express18h
Q3FY25: GSK pharma’s profit surges 4X to Rs 229 crore; Revenue up 18 percent
In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...
Cutting NIH funding puts my life on the line — and maybe yours as well
Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...